China Health Group Limited
China Health Group Limited (0673.HK) Stock Overview
Explore China Health Group Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
147.5M
P/E Ratio
-3.42
EPS (TTM)
$-0.09
ROE
-0.89%
0673.HK Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of China Health Group Limited (0673.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 63.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.33.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.42 and a market capitalization of 147.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
China Health Group Limited, an investment holding company, engages in the distribution and services of medical equipment and consumables, and operation and management of hospitals in the People's Republic of China. It is also involved in business factoring business, as well as property investment business. The company was formerly known as China HealthCare Holdings Limited and changed its name to China Health Group Limited in September 2015. The company is headquartered in Central, Hong Kong.
Ho Chung
118
China Insurance Group Building, Central
1996